News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Ballal Rahul D.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/15/2023 |
4
| Ballal Rahul D. (Director) has filed a Form 4 on AGIOS PHARMACEUTICALS, INC.|
Txns:
| Exercised 2,302 restricted stock units
@ $0 |
|
| 02/22/2023 |
4
| Ballal Rahul D. (CEO) has filed a Form 4 on IMARA Inc.|
Txns:
| Sold 32,861 shares
@ $4.66, valued at
$153.1k
|
|
| 02/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/15/2022 |
4
| Ballal Rahul D. (Director) has filed a Form 4 on AGIOS PHARMACEUTICALS, INC.|
Txns:
| Granted 37,947 options to buy
@ $25.99, valued at
$986.2k
Granted 6,906 restricted stock units
@ $0 |
|
| 02/01/2022 |
4
| Ballal Rahul D. (CEO) has filed a Form 4 on IMARA Inc.|
Txns:
| Granted 131,400 shares
@ $0
Granted 131,400 options to buy
@ $1.38, valued at
$181.3k
|
|
| 02/01/2021 |
4
| Ballal Rahul D. (CEO) has filed a Form 4 on IMARA Inc.|
Txns:
| Granted 133,350 options to buy
@ $13.05, valued at
$1.7M
|
|
| 12/21/2020 |
4
| Ballal Rahul D. (CEO) has filed a Form 4 on IMARA Inc.|
Txns:
| Sold 4,999 shares
@ $25, valued at
$125k
Exercised 4,999 options to buy
@ $3.15, valued at
$15.7k
|
|
| 12/16/2020 |
4
| Ballal Rahul D. (CEO) has filed a Form 4 on IMARA Inc.|
Txns:
| Sold 1 shares
@ $25, valued at
$25
Exercised 1 options to buy
@ $3.15, valued at
$3.2 |
|
|
|